Search Clinical Trials
 
By Condition
 
By Location (USA)
 
By Location (Other)
 
By Sponsor
 
Resources
 
Privacy Policy
 
About Us
Disclaimer
Raloxifene and Goserelin in Preventing Breast Cancer in Women With a Family History of Breast Cancer Clinical Trials Information presented on Clinical Trials Search is not designed to be a substitute for proven healthcare advice, travels to or treatment by using a genuine medical doctor. We are not physicians. Always confer with your doctor on Raloxifene and Goserelin in Preventing Breast Cancer in Women With a Family History of Breast Cancer conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. Raloxifene and Goserelin in Preventing Breast Cancer in Women With a Family History of Breast Cancer Clinical research trials and Raloxifene and Goserelin in Preventing Breast Cancer in Women With a Family History of Breast Cancer healthcare trials take place in many of cities across the United States of America. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally evaluate the effectiveness of new drugs. The function of the studies / undertakings is to answer specific human medical questions. Clinical trials are a popular means for mDs, government agencies, and private sector companies to find treatments for all forms of conditions, including Raloxifene and Goserelin in Preventing Breast Cancer in Women With a Family History of Breast Cancer. Raloxifene and Goserelin in Preventing Breast Cancer in Women With a Family History of Breast Cancer Clinical Trials and other clinical trials allow for volunteers to access medical treatment alternatives before they are available to the masses. Many times the test subjects undergo treatment for without cost, and occasionally they are compensated for their time. Occasionally there is a cost for a Raloxifene and Goserelin in Preventing Breast Cancer in Women With a Family History of Breast Cancer clinical trial. Test subjects oftentimes recieve the best healthcare possible for their Raloxifene and Goserelin in Preventing Breast Cancer in Women With a Family History of Breast Cancer condition. Hazards are a reality, nonetheless, and might include additional or frequent doctor trips, healthcare hazards (perhaps life-jeopardizing), and/or the treatment being ineffective. Trials are federally regulated with rigid guidelines to protect clinical trials subjects.

Home > "R" Clinical Trials Conditions > Raloxifene and Goserelin in Preventing Breast Cancer in Women With a Family History of Breast Cancer

Raloxifene and Goserelin in Preventing Breast Cancer in Women With a Family History of Breast Cancer



Raloxifene and Goserelin in Preventing Breast Cancer in Women With a Family History of Breast Cancer

For Condition: Breast Cancer
Status: Recruiting
Sponsor(s): National Cancer Research Institute (NCRI) ,
Synopsis: RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development or recurrence of cancer. The use of raloxifene and goserelin may be effective in preventing breast cancer. PURPOSE: Randomizedpilot study to study the effectiveness of combining raloxifene and goserelin in preventing breast cancer in women who have a family history of breast cancer.
Details: OBJECTIVES: - Compare the feasibility of raloxifene and goserelin versus no medical intervention in women at high genetic risk for developing breast cancer. - Compare the incidence of adverse effects in patients treated with these regimens. - Compare the effect of these regimens on bone density, biochemical markers of bone turnover, and lipid profiles in these patients. - Compare the quality of life of patients treated with these regimens. OUTLINE: This is a randomized, multicenter study. Patients are stratified according to participating center. Patients are randomized to one of two treatment arms. - Arm I: Patients receive goserelin subcutaneously once every month and oral raloxifene daily for 6-12 months. - Arm II: Patients are screened for breast cancer every 6 months. In both arms, patients undergo annual mammograms. Quality of life is assessed at baseline and at 1, 3, 6, and 12 months. Patients are followed for 5 years. PROJECTED ACCRUAL: A total of 150 patients (75 per treatment arm) will be accrued for this study.
Eligibility:
Study Type:  Interventional, Prevention
Minimum Age/Maximum Age: 30 Years/45 Years
Genders: Both
Protocol Entry Criteria: DISEASE CHARACTERISTICS: - High genetic risk of developing breast cancer defined as one or more of the following: - BRCA1 or BRCA2 germ-line mutation - First-degree relative of known BRCA1 or BRCA2 mutation carrier - Family with 4 or more relatives diagnosed with female or male breast cancer or ovarian cancer before the age of 60 - Two first-degree relatives diagnosed with breast cancer before the age of 40 - p53 germ-line mutation (classical Li-Fraumeni syndrome (LFS) only) - First-degree relative of a carrier in a family with classical LFS - Risk equivalent to any of the above confirmed by clinical geneticist - No evidence of breast cancer by mammography - Suspicious lesions must be confirmed as non-malignant - No prior breast cancer - No prior prophylactic mastectomy - No plan for alternative prevention measures within the next 12 months - Hormone receptor status: - Not specified PATIENT CHARACTERISTICS: Age: - 30 to 45 Sex: - Female Menopausal status: - Premenopausal (follicle-stimulating hormone in premenopausal range if not menstruating) Performance status: - Not specified Life expectancy: - More than 10 years (excluding breast cancer risk) Hematopoietic: - Not specified Hepatic: - Adequate liver function Renal: - Adequate renal function Cardiovascular: - No prior deep vein thrombosis Pulmonary: - No prior pulmonary embolism Other: - Not pregnant - Fertile patients must use effective nonhormonal contraception - No psychological disorder that would preclude study compliance - No prior malignancy within the past 5 years except curatively treated nonmelanoma skin cancer or cervical cancer PRIOR CONCURRENT THERAPY: Biologic therapy: - Not specified Chemotherapy: - Not specified Endocrine therapy: - No concurrent hormonal therapy (e.g., oral contraception or hormone replacement therapy) Radiotherapy: - Not specified Surgery: - See Disease Characteristics Other: - At least 30 days or 5 half-lives since prior investigational drugs - No concurrent anticoagulants
Total Enrollment: 

Location and Contact Information:

Overall Study Official:
AnthonyHowell,  Study Chair,  Christie Hospital N.H.S. Trust

Christie Hospital N.H.S. Trust *Recruiting*
Manchester,  England,  M20 4BX
United Kingdom
Recruiting Anthony  Howell 44-161-446-8037


Additional Information:
Study ID Numbers:  CDR0000069233;  EU-20053,NCRI-IBIS-RAZOR,UKCCCR-IBIS-RAZOR
Study Start Date: 
Record last reviewed: March 2002
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00031850

Other Breast Cancer Studies:
1. Vaccination Against Melanoma and Other Cancers

2. Identification of Genes Associated With Cancer in Patients and Siblings Who Have Cancer

3. Biological Therapy in Treating Patients With Metastatic Cancer

4. A Phase I Trial of Tamoxifen and 9-cis-Retinoic Acid in Breast Cancer Patients

5. Itraconazole Compared With Fluconazole to Prevent Infections in Patients Undergoing Peripheral Stem Cell or Bone Marrow Transplantation

Related Studies:

Other Breast Cancer Clinical Trials
Other England Clinical Trials
Other Manchester Clinical Trials

Raloxifene and Goserelin in Preventing Breast Cancer in Women With a Family History of Breast Cancer
Modify your Search

  Other Breast Cancer Clinical Trials
  Other England Clinical Trials
  Other Manchester Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103